HBI Spotlight

 

More UK outsourcing on the way, and NHS crisis here to stay as doctors look abroad

The government taskforce setting out how the UK NHS will outsource more to tackle its record-breaking backlog is set to be published soon. However while the private sector is willing to help, other long-term issues like workforce and capacity mean public sector issues will persist. HBI speaks to UK healthcare sources to find out more.

German property group selling off €1.3bn portfolio

It has been almost two years since listed Germany-based healthcare property specialist Vonovia acquired its former rival Deutsche Wohnen. We speak to three Germany-based experts to find about more about the ongoing sale of its £1.3bn property portfolio.

M&A set to bounce-back in Q2?

Economic uncertainty and concerns about a looming recession led to a slowdown in M&A deal flow in H2 last year. 2023 has got off to a slow start too - with a dearth of larger deals in particular. But HBI hears Q2 could see the start of the bounce back - and that even the threat of a global banking crisis isn't dampening the enthusiasm of PE firms, which have other sources of capital.

Doctors offered substantial referral bonuses to recruit colleagues

In the increasingly competitive battle for top talent, some private hospitals in the UK - including some of the US-owned hospitals in London - are putting referral schemes worth thousands of pounds in place for doctors who refer potential colleagues to for-profit groups. Golden hellos are also being deployed. HBI speaks to London analysts and a workforce expert to find out more.

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Spire returns to profit, but shares still fall

Shareholders did not give UK hospital group Spire’s full year results a warm reception, despite a return to profit, generally strong financials, and the continued viability of the UK market. HBI talks to market experts to find out why.

Shareholders unconvinced by “future Fresenius”

Michael Sen, CEO of multinational healthcare conglomerate Fresenius, finally set out his long-awaited plan for a “Future Fresenius” at the group’s end of year results this week. But is it a radical shake up, or PR puff? HBI investigates why shareholders appear unconvinced.

Denmark plans hospital outsourcing hike – and tariff cuts

The Danish government has set out plans to increase its use of the private hospital sector. Those plans will see for-profit operators allowed to treat publicly-funded patients more, but also include significant tariff cuts.

Fresenius to deconsolidate FMC

Michael Sen, the new CEO of multinational health care conglomerate Fresenius, is making preparations to deconsolidate struggling dialysis subsidiary Fresenius Medical Care (FMC). The plans fall short of full divestment and may not be radical enough to appease investors.

Find Us